Call for Abstract
Scientific Program
3rd International Conference on Pharmaceutical Chemistry, will be organized around the theme “Recent Advancements, Innovations and future approaches in the fields of Pharmaceutical Chemistry & Drug Discovery process”
Pharmaceutical Chemistry 2018 is comprised of 19 tracks and 157 sessions designed to offer comprehensive sessions that address current issues in Pharmaceutical Chemistry 2018.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
- Track 1-1Hit to lead
- Track 1-2Lead identification and optimization
- Track 1-3Chemical biology approach to drug discovery
- Track 1-4Plant derived drugs in drug discovery
- Track 1-5Computer aided drug models in drug discovery
- Track 1-6Drug transporters in drug discovery
- Track 1-7A novel paradigm of drug discovery
- Track 1-8Clinical Drug Development
- Track 2-1Pharmacotoxicology
- Track 2-2Hospital Pharmacy& Health practice
- Track 2-3Specialist Roles in Pharmacy
- Track 2-4Conference Highlights Biopharmaceutics Clinical Drug Development and Therapeutics Clinical Pharmacology Clinical Pharmacy: Activities and Prescriptions
- Track 3-1Nanomedicine
- Track 3-2Nanotechnology
- Track 3-3Nanofabrications, Nano Fluidics, Nano Robotics, Nano Drugs
- Track 3-4Emerging fields of Nanomedicine and Nanotechnology.
- Track 4-1Molecular Biotechnology: From DNA Sequence to Therapeutic Protein
- Track 4-2Production and Purification of Recombinant Proteins
- Track 4-3Immunogenicity of Therapeutic Proteins
- Track 4-4Economic Considerations in Medical Biotechnology
- Track 4-5Monoclonal Antibodies in Various Diseases
- Track 4-6Biomolecules used to develop targeted drug therapies
- Track 4-7Biomolecules that elicit specific ligand-receptor interactions
- Track 4-8Oligopeptides and Nucleic acids
- Track 4-9Design of proteins
- Track 5-1Pharmacological in vitro and in vivo investigations
- Track 5-2Toxicology and Pharmacogenomics
- Track 5-3Biomolecular Interactions and Thermodynamic
- Track 5-4Bioassay and Dose effect relationships
- Track 5-5Drug-receptor interactions on the molecular level
- Track 5-6Drug Transport across Biological Membranes
- Track 5-7Various ScreeningMethods
- Track 5-8Enzyme Inhibitors
- Track 5-9Cancer Therapy
- Track 6-1Pharmaceutical Processing Equipment
- Track 6-2Pharmaceutical Machinery: Tableting, Tube Filling, Liquid Filling, Labeling
- Track 6-3Pharmaceutical Machinery: Cartoning and Packaging
- Track 6-4Pharmaceutical Machinery: Standards
- Track 6-5Pharmaceutical Machinery: Technology
- Track 6-6Pharmaceutical Manufacturing Equipment
- Track 6-7Laboratory & Quality Control Equipment
- Track 6-8Pharmaceutical Machinery: Global Market
- Track 7-1Various Separation Techniques
- Track 7-2Electroanalytical methods: Potentiometry and voltammetry
- Track 7-3Spectroscopy: UV, Mass Spectroscopy and other Spectroscopies techniques
- Track 7-4NMR Spectroscopy
- Track 7-5Chromatography techniques
- Track 7-6Radioanalytical chemistry
- Track 7-7Gravimetric analysis
- Track 7-8UPLC and HPLC
- Track 7-9Titrimetry and X-ray Crystallography
- Track 7-10Mass Spectrometry
- Track 8-1Design, manufacture and use of efficatious dosage forms
- Track 8-2Types of Formulation: Enteral, Parenteral and Topical
- Track 8-3Water-miscible formulations
- Track 8-4Other formulations
- Track 8-5Pesticide formulation
- Track 8-6Recent Developments in Dosage Form Design
- Track 8-7Establishing the Bioequivalence of Pharmaceutical Products
- Track 9-1Nomenclature of Heterocyclic Chemistry
- Track 9-2Six-Membered Heterocycles: Synthesis and its Activity
- Track 9-3Five-Membered Heterocycles: Synthesis and its Activity
- Track 9-4Four-Membered Heterocycles: Synthesis and its Activity
- Track 9-5Three-Membered Heterocycles: Synthesis and its Activity
- Track 9-6General Strategies for Heterocycle Synthesis
- Track 9-7Reations involved in Heterocyclic chemistry
- Track 9-8Functional Group Chemistry
- Track 9-9Classification of Heterocyclic Chemistry
- Track 9-10Some Polycyclic Heterocycles Compounds: Synthesis and its Activity
- Track 10-1Catalyst: Acid and Base Catalyzed Reactions
- Track 10-2Characterization of inorganic compounds
- Track 10-3Reactions at ligands
- Track 10-4Redox reactions
- Track 10-5Transition Metal Catalysis
- Track 10-6Free-Radical Reactions
- Track 10-7Molecular Rearrangements
- Track 10-8Electrophilic and Nucleophilic Substitution
- Track 10-9Organometallic Reagents and Compounds
- Track 10-10Synthetic inorganic chemistry
- Track 11-1Physicochemical and biological factors that contribute to drug action
- Track 11-2Medicinal Radiocompounds or Radiopharmaceuticals
- Track 11-3Global Pharmaceutical Policy
- Track 11-4Impurities and Impurity Profile Significance in API
- Track 11-5Design of Safer Chemicals and Products
- Track 11-6Process Chemistry Considerations
- Track 11-7Structure-activity relationships of drug Moiety
- Track 11-8Synthetic chemistry including combinatorial methods
- Track 11-9In vivo and in vitro biotransformations of drugs
- Track 11-10Modelling and designing of small compounds
- Track 12-1Drug Delivery using Nanotechnology
- Track 12-2Drug carrier
- Track 12-3Neural drug delivery systems
- Track 12-4Acoustic targeted drug delivery
- Track 12-5Thin film drug delivery
- Track 12-6Other Controlled Drug Delivery Systems
- Track 12-7Liposomal and Target Delivery System
- Track 12-8Beaded Delivery Systems
- Track 12-9Identification and validation of (emerging) drug targets
- Track 12-10Strategies for drug delivery to the brain
- Track 13-1In-Silico molecular design software and tools
- Track 13-2Structure based drug design
- Track 13-3Ligand-based Drug Design
- Track 13-4Rational Drug Design
- Track 13-5De Novo Ligand design
- Track 13-6Computer-Assisted Drug Design
- Track 13-7Molecular modelling and drug design
- Track 13-8Computer graphics in drug design
- Track 14-1The Metrics of Green Chemistry
- Track 14-2Green Chemistry and Sustainability
- Track 14-3Designing Sustainable Solutions
- Track 14-4Principles Applied in Green Chemistry
- Track 14-5Green Chemistry Focuses on Inherent Hazards
- Track 14-6Green Chemistry Tackles the Grand Challenges
- Track 14-7Adverse Effects of Chemicals on Health and the Environment
- Track 14-8Green Chemistry Problems
- Track 15-1Generating human proteome antibodies via phage display and directed evolution
- Track 15-2Classical or Quantum mechanic
- Track 15-3Probing and modulating membrane proteins
- Track 15-4De novo design of catalytic and membrane proteins
- Track 15-5Creating fluorescent probes targeting the genome and key bio-pathways
- Track 15-6Investigating cellular interactions in tissues
- Track 15-7Globally analyzing and dissecting apoptosis
- Track 15-8Proximity tagging of protein-protein interactions
- Track 15-9Monitoring enzyme activity and disease biomarkers
- Track 16-1Biosynthetic Mechanisms
- Track 16-2Prostaglandins and Steriods
- Track 16-3Alkaloids and Terpenes
- Track 16-4Synthesis of Amino Acids
- Track 16-5Peptides & Proteins
- Track 16-6The Primary Structure of DNA
- Track 16-7The Secondary & Tertiary Structures of DNA
- Track 16-8RNA and Protein Synthesis
- Track 16-9Isolation and Structural elucidation of Natural Products
- Track 17-1Nanobiopharmaceutics
- Track 17-2Synthesis of Vaccines, blood and blood components
- Track 17-3Recombinant therapeutic protein, and living cells used in cell therapy
- Track 17-4Large-scale production: Transgenics
- Track 17-5Allergenics and somatic cells
- Track 17-6Biologics: Sugars, proteins, or nucleic acids
- Track 17-7Medical devices
- Track 18-1Discovery of biomolecules through metagenomics
- Track 18-2Chemical approaches to stem-cell biology
- Track 18-3Metal complexes in medicine
- Track 18-4Bioorganic and Bioinorganic Chemistry
- Track 18-5Synthetic biology
- Track 18-6Enzymology
- Track 18-7Genome Analysis
- Track 18-8Chemical and Molecular dynamics
- Track 18-9Applications of Chemical Biology in Drug Discovery
- Track 19-1Application of Medicinal Chemistry to Pharmacology
- Track 19-2Computer aided drug design (CADD): Virtual screening and Molecular modeling
- Track 19-3High-Throughput Screening
- Track 19-4Design and application of prodrugs
- Track 19-5Drug-Receptor complex/Interactions
- Track 19-6Molecular modification of known drugs
- Track 19-7Prodrugs Studies
- Track 19-8Molecular mechanics